FAQs & How to use this site
Home | About Us | Contact Us
The Front Line
The Front Line: Charles D. Blanke, MD, SWOG Chair

PREVIOUS POSTS November 2017

October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 JUNE 2016 MAY 2016 APRIL 2016 MARCH 2016 FEB 2016 JAN 2016 DEC 2015 NOV 2015 OCT 2015 SEP 2015 AUG 2015 JUL 2015 JUN 2015 MAY 2015 APR 2015 MAR 2015 FEB 2015 JAN 2015 DEC 2014 NOV 2014 OCT 2014 SEP 2014 AUG 2014 JUL 2014 JUN 2014 MAY 2014 APR 2014 MAR 2014 FEB 2014 JAN 2014 DEC 2013 NOV 2013 OCT 2013 SEP 2013 AUG 2013 JUL 2013

We’ve Hit M and M and M: A Major Membership Milestone

July 1, 2016 - SWOG members play second fiddle only to our patients, in terms of importance to the group. That’s why I am so pleased we’ve tipped the scales at over 1,000 member sites – 1,032 to be exact. That means that our cancer clinical trials are available to more patients – in more hospitals, clinics, physician practices, and health care organizations – than at any time in our history. It’s a great milestone to hit as we celebrate our 60th anniversary.

We leaped over the 1,000 site mark last week, when the Wisconsin NCORP came on board. This system includes more than two dozen hospitals, clinics, and treatment centers in Wisconsin and Michigan. A warm welcome to Principal Investigator Dr. Adedayo A. Onitilo and Head Clinical Research Associate Brian Zaleski. We are glad to have you join!

Investigators in the NCI’s Community Oncology Research Program are certainly driving our recent growth. In just the last year, we’ve added NCORP member sites in several states, including Iowa, Massachusetts, Alaska, Georgia, Virginia, South Carolina, Utah, and Arizona. We have made a concerted effort to recruit and retain members in community hospitals and clinics, including the addition last year of the NCORP clinical trials workshop, the group meeting session that walks investigators and research professionals through the unique management of NCORP clinical trials.

New membership rules are another driver of our growth. In 2014, we revised our policies to allow for three categories of members – full, affiliate, and component. This change, approved by the Board of Governors, accommodated smaller sites that accrued consistently to our trials but weren’t big enough to meet old accrual benchmarks.

Finally, we’re growing because we’re broadening eligibility in other ways. We’ve welcomed The Jackson Laboratory and Cold Spring Harbor Laboratory – two of the best basic science labs in the nation. We’ve actively recruited VA hospitals. And we are making a big play internationally, with members in Canada, Columbia, Korea, Mexico, Peru, and Saudi Arabia, and some new potential in Israel and Australia. Diversity, in our membership as well as in our patients, is making our group and our trials better.

So, in SWOG’s 60th year and on the eve of America’s birthday, we’ve got a lot to celebrate. We’re now 12,466 members strong, at 1,032 sites, in 46 states, and six other countries. We’ve come a long way – and will continue our steady progress. Happy Fourth of July!

Reminder: The 58th Annual Meeting of the American Society of Hematology (ASH) will be held December 3-6, 2016, in San Diego. The abstract submission deadline is Thursday, August 4, 2016, 11:59 p.m. (PDT), and the SWOG internal deadline is Thursday, July 21, 2016. SWOG abstracts must be submitted to pubs@swog.org for processing two weeks prior to the conference submission deadline to allow for authorship review, obtaining required approvals, and circulation to appropriate reviewers including NCI/CTEP and, where indicated, industry collaborators.


SWOG Logo Disclaimer | Copyright ©1999-2017 SWOG. All rights reserved.
Design and Hosting by nuMedia
SWOG is FISMA CertifiedSWOG is FISMA Certified